Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation.

Kode, Ravi

Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. [electronic resource] - Clinical transplantation Aug 2003 - 369-76 p. digital

Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article

0902-0063

10.1034/j.1399-0012.2003.00061.x doi


Antibodies, Monoclonal--therapeutic use
Basiliximab
Cadaver
Cyclosporine--therapeutic use
Drug Therapy, Combination
Female
Graft Rejection--prevention & control
Graft Survival
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation
Male
Middle Aged
Muromonab-CD3--therapeutic use
Recombinant Fusion Proteins